image 1
Posted by: Dr. Thomas John MD


Pubblicazioni Scientifiche:

  1. de Koning MN, Weissenborn SJ, Abeni D, Bouwes Bavinck JN, Euvrard S, Green AC, Harwood CA, Naldi L, Neale R, Nindl I, Proby CM, Quint WG, Sampogna F, ter Schegget J, Struijk L, Wieland U, Pfister HJ, Feltkamp MC; EPI-HPV-UV-CA group (D.Abeni, F.Sampogna, T.J. Mannooranparampil, N. Melo-Salcedo, S. Simoni, G.P. Petasecca Donati, C. Masini and C. Deppermann Fortes) Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma. J Gen Virol. 2009 Jul;90(Pt 7):1611-21. Epub 2009 Mar 25.
  2. Waterboer T, Neale R, Michael KM, Sehr P, de Koning MN, Weissenborn SJ, Sampogna F, Abeni D, Green AC, Bouwes Bavinck JN, Pawlita M; EPI-HPV-UV-CA group (D.Abeni, F.Sampogna, T.J. Mannooranparampil, N. Melo-Salcedo, S. Simoni, G.P. Petasecca Donati, C. Masini and C. Deppermann Fortes) Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia. Gen Virol. 2009 Aug;90(Pt 8):1986-98. Epub 2009 Apr 22.
  3. Weissenborn SJ, Neale R, de Koning MN, Waterboer T, Abeni D, Bouwes Bavinck JN, Wieland U, Pfister HJ; EPI-HPV-UV-CA group (D.Abeni, F.Sampogna, T.J. Mannooranparampil, N. Melo-Salcedo, S. Simoni, G.P. Petasecca Donati, C. Masini and C. Deppermann Fortes) Prevalence and multiplicity of cutaneous beta papilloma viruses in plucked hairs depend on cellular DNA input. J Virol Methods. 2009 Nov;161(2):280-3. Epub 2009 Jul 8.
  4. Mallitt KA, O'Rourke P, Bouwes Bavinck JN, Abeni D, de Koning MN, Feltkamp MC, Green AC, Quint WG, Michael KM, Pawlita M, Pfister H, Weissenborn S, Waterboer T, Neale RE; EPI-HPV-UV-CA Group (D.Abeni, F.Sampogna, T.J. Mannooranparampil, N. Melo-Salcedo, S. Simoni, G.P. Petasecca Donati, C. Masini and C. Deppermann Fortes). An analysis of clustering of betapapillomavirus antibodies.J Gen Virol. 2010 Aug;91(Pt 8):2062-7.
  5. Fortes C, Mastroeni S, Bakos L, Antonelli G, Alessandroni L, Pilla MA, Alotto M, Zappalà A, Manooranparampil T, Bonamigo R, Pasquini P, Melchi F. Identifying individuals at high risk of melanoma: a simple tool. Eur J Cancer Prev 2010;19(5): 393-400.
  6. Renzi C, Mastroeni S, Passarelli F, Mannooranparampil TJ, Caggiati A, Potenza C, Pasquini P. Factors associated with large cutaneous squamous cell carcinomas. J Am Acad Dermatol 2010 Sep;63(3):404-11.
  7. Bouwes Bavinck JN, Neale RE, Abeni D, Euvrard S, Green AC, Harwood CA, de Koning MN, Naldi L, Nindl I, Pawlita M, Pfister H, Proby CM, Quint WG, ter Schegget J, Waterboer T, Weissenborn S, Feltkamp MC; EPI-HPV-UV-CA group (D.Abeni, F.Sampogna, T.J. Mannooranparampil, N. Melo-Salcedo, S. Simoni, G.P. Petasecca Donati, C. Masini and C. Deppermann Fortes). Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma.Cancer Res. 2010 Dec 1;70(23):9777-86.
  8. Renzi C, Mastroeni S, Passarelli F, Mannooranparampil TJ, Caggiati A, Potenza C, Pasquini P. Delay in Diagnosis and Treatment of Squamous Cell Carcinoma of the Skin. Acta Derm Venereol 2010; 90(6): 595–601.
  9. Renzi C, Mastroeni S, Mannooranparampil TJ, Passarelli F, Pasquini P. Timely diagnosis of cutaneous squamous cell carcinoma: the GP's role. Fam.Pract. 2011 Jun;28(3):277-9.
  10. Proby CM, Harwood CA, Neale RE, Green AC, Euvrard S, Naldi L, Tessari G, Feltkamp MC, de Koning MN, Quint WG, Waterboer T, Pawlita M, Weissenborn S, Wieland U, Pfister H, Stockfleth E, Nindl I, Abeni D, Schegget JT, Bouwes Bavinck JN; EPI-HPV-UV-CA group (D.Abeni, F.Sampogna, T.J. Mannooranparampil, N. Melo-Salcedo, S. Simoni, G.P. Petasecca Donati, C. Masini and C. Deppermann Fortes). A case-control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients. Am J Transplant. 2011 Jul;11(7):1498-508